Logo image of CRWD

CROWDSTRIKE HOLDINGS INC - A (CRWD) Stock Fundamental Analysis

USA - NASDAQ:CRWD - US22788C1053 - Common Stock

537.55 USD
+7.77 (+1.47%)
Last: 11/14/2025, 8:00:00 PM
538.8 USD
+1.25 (+0.23%)
After Hours: 11/14/2025, 8:00:00 PM
Fundamental Rating

4

CRWD gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. CRWD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CRWD is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CRWD had positive earnings in the past year.
CRWD had a positive operating cash flow in the past year.
In the past 5 years CRWD reported 4 times negative net income.
In the past 5 years CRWD always reported a positive cash flow from operatings.
CRWD Yearly Net Income VS EBIT VS OCF VS FCFCRWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of -3.20%, CRWD is in line with its industry, outperforming 47.69% of the companies in the same industry.
Looking at the Return On Equity, with a value of -7.91%, CRWD is in line with its industry, outperforming 49.82% of the companies in the same industry.
Industry RankSector Rank
ROA -3.2%
ROE -7.91%
ROIC N/A
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
CRWD Yearly ROA, ROE, ROICCRWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

CRWD has a better Gross Margin (74.16%) than 62.99% of its industry peers.
CRWD's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for CRWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
CRWD Yearly Profit, Operating, Gross MarginsCRWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

6

2. Health

2.1 Basic Checks

CRWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRWD has more shares outstanding
CRWD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CRWD has an improved debt to assets ratio.
CRWD Yearly Shares OutstandingCRWD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CRWD Yearly Total Debt VS Total AssetsCRWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 15.19 indicates that CRWD is not in any danger for bankruptcy at the moment.
CRWD's Altman-Z score of 15.19 is amongst the best of the industry. CRWD outperforms 91.46% of its industry peers.
CRWD has a debt to FCF ratio of 0.72. This is a very positive value and a sign of high solvency as it would only need 0.72 years to pay back of all of its debts.
CRWD has a Debt to FCF ratio of 0.72. This is in the better half of the industry: CRWD outperforms 77.58% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that CRWD is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.20, CRWD is in line with its industry, outperforming 46.98% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.72
Altman-Z 15.19
ROIC/WACCN/A
WACC10.96%
CRWD Yearly LT Debt VS Equity VS FCFCRWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.88 indicates that CRWD should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.88, CRWD is in line with its industry, outperforming 58.01% of the companies in the same industry.
CRWD has a Quick Ratio of 1.88. This is a normal value and indicates that CRWD is financially healthy and should not expect problems in meeting its short term obligations.
CRWD has a Quick ratio of 1.88. This is comparable to the rest of the industry: CRWD outperforms 58.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.88
Quick Ratio 1.88
CRWD Yearly Current Assets VS Current LiabilitesCRWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

8

3. Growth

3.1 Past

CRWD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.21%.
The Earnings Per Share has been growing by 79.46% on average over the past years. This is a very strong growth
The Revenue has grown by 23.46% in the past year. This is a very strong growth!
The Revenue has been growing by 52.37% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-3.21%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-10.58%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%21.28%

3.2 Future

CRWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.12% yearly.
The Revenue is expected to grow by 21.83% on average over the next years. This is a very strong growth
EPS Next Y-4.65%
EPS Next 2Y11.31%
EPS Next 3Y17.34%
EPS Next 5Y22.12%
Revenue Next Year21.76%
Revenue Next 2Y21.85%
Revenue Next 3Y21.92%
Revenue Next 5Y21.83%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CRWD Yearly Revenue VS EstimatesCRWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 5B 10B 15B
CRWD Yearly EPS VS EstimatesCRWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 148.49, the valuation of CRWD can be described as expensive.
CRWD's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 25.89, CRWD is valued quite expensively.
A Price/Forward Earnings ratio of 110.39 indicates a quite expensive valuation of CRWD.
60.85% of the companies in the same industry are cheaper than CRWD, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CRWD to the average of the S&P500 Index (34.59), we can say CRWD is valued expensively.
Industry RankSector Rank
PE 148.49
Fwd PE 110.39
CRWD Price Earnings VS Forward Price EarningsCRWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

CRWD's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 129.97
EV/EBITDA N/A
CRWD Per share dataCRWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as CRWD's earnings are expected to grow with 17.34% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.31%
EPS Next 3Y17.34%

0

5. Dividend

5.1 Amount

CRWD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CROWDSTRIKE HOLDINGS INC - A

NASDAQ:CRWD (11/14/2025, 8:00:00 PM)

After market: 538.8 +1.25 (+0.23%)

537.55

+7.77 (+1.47%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-27 2025-08-27/amc
Earnings (Next)12-02 2025-12-02/amc
Inst Owners73.69%
Inst Owner Change-3.3%
Ins Owners3.03%
Ins Owner Change-6.06%
Market Cap134.90B
Revenue(TTM)4.34B
Net Income(TTM)-296.99M
Analysts76.33
Price Target497.4 (-7.47%)
Short Float %2.5%
Short Ratio1.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.62%
Min EPS beat(2)9.3%
Max EPS beat(2)9.95%
EPS beat(4)4
Avg EPS beat(4)12.71%
Min EPS beat(4)9.3%
Max EPS beat(4)18.62%
EPS beat(8)8
Avg EPS beat(8)9.93%
EPS beat(12)12
Avg EPS beat(12)12.73%
EPS beat(16)16
Avg EPS beat(16)20.56%
Revenue beat(2)0
Avg Revenue beat(2)-1.13%
Min Revenue beat(2)-2%
Max Revenue beat(2)-0.26%
Revenue beat(4)2
Avg Revenue beat(4)-0.23%
Min Revenue beat(4)-2%
Max Revenue beat(4)0.82%
Revenue beat(8)2
Avg Revenue beat(8)-0.57%
Revenue beat(12)3
Avg Revenue beat(12)-0.49%
Revenue beat(16)7
Avg Revenue beat(16)0.28%
PT rev (1m)0.95%
PT rev (3m)3.8%
EPS NQ rev (1m)0.02%
EPS NQ rev (3m)3.35%
EPS NY rev (1m)0.02%
EPS NY rev (3m)4.52%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)-1.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 148.49
Fwd PE 110.39
P/S 31.08
P/FCF 129.97
P/OCF 97.14
P/B 35.91
P/tB 49.5
EV/EBITDA N/A
EPS(TTM)3.62
EY0.67%
EPS(NY)4.87
Fwd EY0.91%
FCF(TTM)4.14
FCFY0.77%
OCF(TTM)5.53
OCFY1.03%
SpS17.3
BVpS14.97
TBVpS10.86
PEG (NY)N/A
PEG (5Y)N/A
Graham Number34.92
Profitability
Industry RankSector Rank
ROA -3.2%
ROE -7.91%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.16%
FCFM 23.91%
ROA(3y)-0.84%
ROA(5y)-2.48%
ROE(3y)-3.08%
ROE(5y)-8.55%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.6%
GM growth 5Y1.2%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 0.72
Debt/EBITDA N/A
Cap/Depr 143.34%
Cap/Sales 8.08%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.88
Quick Ratio 1.88
Altman-Z 15.19
F-Score3
WACC10.96%
ROIC/WACCN/A
Cap/Depr(3y)197.98%
Cap/Depr(5y)189.45%
Cap/Sales(3y)9.2%
Cap/Sales(5y)8.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.21%
EPS 3Y79.46%
EPS 5YN/A
EPS Q2Q%-10.58%
EPS Next Y-4.65%
EPS Next 2Y11.31%
EPS Next 3Y17.34%
EPS Next 5Y22.12%
Revenue 1Y (TTM)23.46%
Revenue growth 3Y39.65%
Revenue growth 5Y52.37%
Sales Q2Q%21.28%
Revenue Next Year21.76%
Revenue Next 2Y21.85%
Revenue Next 3Y21.92%
Revenue Next 5Y21.83%
EBIT growth 1Y-638.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year54.6%
EBIT Next 3Y38.46%
EBIT Next 5Y36.81%
FCF growth 1Y29.99%
FCF growth 3Y34.28%
FCF growth 5Y143.57%
OCF growth 1Y30.79%
OCF growth 3Y33.96%
OCF growth 5Y69.1%

CROWDSTRIKE HOLDINGS INC - A / CRWD FAQ

Can you provide the ChartMill fundamental rating for CROWDSTRIKE HOLDINGS INC - A?

ChartMill assigns a fundamental rating of 4 / 10 to CRWD.


What is the valuation status of CROWDSTRIKE HOLDINGS INC - A (CRWD) stock?

ChartMill assigns a valuation rating of 1 / 10 to CROWDSTRIKE HOLDINGS INC - A (CRWD). This can be considered as Overvalued.


Can you provide the profitability details for CROWDSTRIKE HOLDINGS INC - A?

CROWDSTRIKE HOLDINGS INC - A (CRWD) has a profitability rating of 3 / 10.


What is the financial health of CROWDSTRIKE HOLDINGS INC - A (CRWD) stock?

The financial health rating of CROWDSTRIKE HOLDINGS INC - A (CRWD) is 6 / 10.


What is the expected EPS growth for CROWDSTRIKE HOLDINGS INC - A (CRWD) stock?

The Earnings per Share (EPS) of CROWDSTRIKE HOLDINGS INC - A (CRWD) is expected to decline by -4.65% in the next year.